Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study)
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (7), 869-871
- https://doi.org/10.1016/j.amjcard.2004.12.014
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY StudyInt. Journal of Clinical Pharmacology and Therapeutics, 2004
- Docosahexaenoic acid supplementation alters plasma phospholipid fatty acid composition in hyperlipidemic children: Results from the Endothelial Assessment of Risk from Lipids in Youth (EARLY) studyNutrition Research, 2004
- Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on the oxidizability and thrombogenicity of low-density lipoproteinAtherosclerosis, 2004
- Associations of low density lipoprotein particle composition with atherogenicityCurrent Opinion in Lipidology, 2004
- Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemiaAmerican Heart Journal, 2002
- LDL Size and Risk of Coronary Heart Disease in Elderly Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosisAtherosclerosis, 1996
- Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle sizeAtherosclerosis, 1992
- Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.Circulation, 1990
- Docosahexaenoic acid (22:6n3)-induced relaxation of the rat aortaEuropean Journal of Pharmacology, 1990